Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Anticataract and NGF production-enhancing compounds

Sep. 27, 1996

No Comments

Wakamoto claims diclofenac eyedrop formulation

Sep. 20, 1996

No Comments

AGN-193080, a peripherally acting alpha2-agonist from Allergan

Sep. 20, 1996

No Comments

Xalatan Solution now available for glaucoma

Sep. 20, 1996

No Comments

U.S. approval for glaucoma medication

Sep. 13, 1996

No Comments

Potent antiinflammatory/antioxidant agents from Alcon

Aug. 30, 1996

No Comments

Study finds latanoprost more effective than timolol

Aug. 30, 1996

No Comments

Glaucoma diagnostic under investigation in Germany

Aug. 23, 1996

No Comments

Cannabinoid receptor ligands for glaucoma reported by Merck Frosst

Aug. 16, 1996

No Comments

Cefazolin/fluoroquinolone combinations show favorable antibacterial activity

July 26, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

Anticataract and NGF production-enhancing compounds

Wakamoto claims diclofenac eyedrop formulation

AGN-193080, a peripherally acting alpha2-agonist from Allergan

Xalatan Solution now available for glaucoma

U.S. approval for glaucoma medication

Potent antiinflammatory/antioxidant agents from Alcon

Study finds latanoprost more effective than timolol

Glaucoma diagnostic under investigation in Germany

Cannabinoid receptor ligands for glaucoma reported by Merck Frosst

Cefazolin/fluoroquinolone combinations show favorable antibacterial activity

Today's news in brief

Today's news in brief

J&J’s Ottava robotic system approved for US pivotal trial

‘Evo’ AI can design complete genomes

Medtronic receives CE mark for next generation Endoflip system

Ocular RSS

Ocular
RSS